Phytochemical Name : Alizarin

Properties Information
PhytoCAT-ID PhytoCAT-784
Phytochemical name or plant extracts Alizarin
PMID 22411621
Literature evidence Importantly, Alizarin had a significantly lower inhibitory activity on normal cells (IC(50) for MSC, 828.6 µg/ml), thereby revealing a selective activity towards malignant cells.
IUPAC name 1,2-dihydroxyanthracene-9,10-dione
Phytochemicals’ class or type of plant extracts Quinone
Source of phytochemicals or plant Extracts Rubia tinctorum
Geographical availability Afghanistan, Albania, Cyprus, East Aegean Is., Greece, India, Iran, Iraq, Italy, Kazakhstan, Kirgizstan, Kriti, Krym, Lebanon-Syria, North Caucasus, Pakistan, Palestine, Sicilia, South European Russi, Tadzhikistan, Transcaucasus, Turkey, Turkey-in-Europe, Turkmenistan, Ukraine, Uzbekistan, Vietnam, West Himalaya, Xinjiang, Yugoslavia
Plant parts Root
Other cancers Breast cancer, Bone cancer
Target gene or protein NA
Gene or Protein evidence NA
Target pathways NA
IC50 62.1 µg/ml against MDA-MB-231
Potency We demonstrated that low dosages of Alizarin strongly inhibited the osteosarcoma (IC(50) for Saos-2, MG-63, and U-2 OS cells, 27.5, 29.0, and 69.9 µg/ml, respectively) and breast carcinoma (IC(50) for MDA-MB-231 cells, 62.1 µg/ml) cell proliferation in vitro. Importantly, Alizarin had a significantly lower inhibitory activity on normal cells (IC(50) for MSC, 828.6 µg/ml), thereby revealing a selective activity towards malignant cells.
Cell line/ mice model MDA-MB-231
Additional information  Furthermore, we found that Alizarin acted through the inhibition of ERK phosphorylation and cell cycle arrest in the S-phase. Finally, Alizarin significantly and strongly impaired both osteosarcoma and breast cancer tumorigenesis.
PubChem ID 6293
Additional PMIDs 15579325 15537303 17092687 34010709 22411621
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:765369-1
Safety NA